We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJIV
3651
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
$2.41M ﹤0.01%
50,304
+36,997
+278% +$1.99M
GEVO icon
3652
Gevo
GEVO
$355M
$2.41M ﹤0.01%
+362,697
New +$2.24M
RDFN
3653
DELISTED
Redfin
RDFN
$2.41M ﹤0.01%
48,056
-171,445
-78% -$9.27M
ATLO icon
3654
AMES National
ATLO
$274M
$2.4M ﹤0.01%
103,311
-37,811
-27% -$891K
IRON icon
3655
Disc Medicine
IRON
$2.93B
$2.4M ﹤0.01%
19,824
+11,299
+133% +$1.54M
TISI icon
3656
Team
TISI
$77.7M
$2.4M ﹤0.01%
79,793
+68,763
+623% +$3.31M
INMB icon
3657
INmune Bio
INMB
$49.2M
$2.4M ﹤0.01%
+123,511
New +$2.38M
WNEB icon
3658
Western New England Bancorp
WNEB
$263M
$2.4M ﹤0.01%
281,269
-201,365
-42% -$1.69M
CCU icon
3659
Compañía de Cervecerías Unidas
CCU
$2.12B
$2.4M ﹤0.01%
138,711
-100,462
-42% -$2M
DBRG icon
3660
DigitalBridge
DBRG
$2.93B
$2.4M ﹤0.01%
99,287
-87,298
-47% -$2.41M
ASND icon
3661
CALL
Ascendis Pharma A/S
ASND
$16B
$2.39M ﹤0.01%
15,000
-20,000
-57% -$2.74M
SE icon
3662
PUT
Sea Limited
SE
$68.1B
$2.39M ﹤0.01%
7,500
QUOT
3663
DELISTED
Quotient Technology Inc
QUOT
$2.39M ﹤0.01%
410,396
+315,879
+334% +$2.65M
HLI icon
3664
Houlihan Lokey
HLI
$8.77B
$2.39M ﹤0.01%
25,916
-118,758
-82% -$10.4M
HIGA.U
3665
DELISTED
H.I.G. Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HIGA.U
$2.38M ﹤0.01%
237,500
CSLT
3666
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.38M ﹤0.01%
1,518,897
-281,461
-16% -$551K
IMRX icon
3667
Immuneering
IMRX
$270M
$2.38M ﹤0.01%
+89,788
New +$2.41M
ANSS
3668
PUT
DELISTED
Ansys
ANSS
$2.38M ﹤0.01%
7,000
+1,500
+27% +$542K
ALHC icon
3669
Alignment Healthcare
ALHC
$3.02B
$2.38M ﹤0.01%
+149,053
New +$2.88M
DOMA.WS
3670
CALL
DELISTED
Doma Holdings, Inc. Warrants, Every 25 warrants will be exercisable for one share of Common Stock at an exercise price of $287.50 per share of Common Stock
DOMA.WS
$2.38M ﹤0.01%
+1,688,919
New +$2.1M
RACB
3671
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$2.38M ﹤0.01%
241,742
-46,987
-16% -$465K
GNTX icon
3672
Gentex
GNTX
$4.99B
$2.38M ﹤0.01%
72,015
-558,495
-89% -$18M
CELH icon
3673
Celsius Holdings
CELH
$7.22B
$2.37M ﹤0.01%
78,876
-416,280
-84% -$10.7M
CMO
3674
DELISTED
Capstead Mortgage Corp.
CMO
$2.37M ﹤0.01%
354,125
+330,354
+1,390% +$2.16M
FSSI
3675
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$2.37M ﹤0.01%
242,202
-213,743
-47% -$2.07M

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.